JBRA Assist. Reprod. 2025;29(3):407-410
EDITORIAL

doi: 10.5935/1518-0557.20250158

Toward clarity: why we need to standardize the term ‘recurrent pregnancy loss’

Luiza Pretto1,2, Eduarda Nabinger1,2, Ivan Sereno Montenegro2, Maria Teresa Vieira Sanseverino1,2,3, Osvaldo Artigalás2, Fernanda Sales Luiz Vianna1,2, Eduardo Pandolfi Passos1,2,4, Lucas Rosa Fraga1,2

1Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
2Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
3Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil
4Fertility Center, Hospital Moinhos de Vento (HMV), Porto Alegre, Brazil

CORRESPONDING AUTHOR:
Lucas Rosa Fraga
Departamento de Ciências Morfológicas
Universidade Federal do Rio Grande do Sul
Porto Alegre - RS - Brazil
Email: lrfraga@ufrgs.br

CONFLICT OF INTEREST
The authors declare no conflicts of interest.

ABSTRACT
Recurrent pregnancy loss (RPL) is a complex reproductive condition that remains difficult to manage. Despite advances in identifying risk factors and treating cases with known causes, about half of the cases are still idiopathic, making effective treatment and prognosis challenging. In addition to clinical hurdles, a major issue in both the literature and medical community is the lack of standardization in terminology and precise definition for RPL. Here, we review the main discrepancies in current definitions and support adopting the term ‘recurrent pregnancy loss’ as the most appropriate and inclusive. We recommend recognizing RPL as a specific subtype of secondary infertility, characterized by two or more pregnancy losses. Standardizing this terminology is crucial for improving diagnosis, research comparison, and patient care in reproductive medicine.

Keywords: infertility, miscarriage, definition standardization, terminology harmonization

INTRODUCTION

Recurrent pregnancy loss (RPL) is an adverse reproductive outcome characterized by more than one pregnancy loss event. Although difficult to estimate, it affects 1-2% of women worldwide (ESHRE Guideline Group on RPL et al., 2023). There are several risk factors for RPL, including genetic causes such as parental chromosomal abnormalities and embryonic aneuploidies; anatomical factors like congenital uterine malformations, intrauterine adhesions, and myomas; immunological disorders, including antiphospholipid antibody syndrome, hereditary and acquired thrombophilias, and autoimmune diseases; and endocrine factors such as polycystic ovary syndrome, thyroid dysfunction, and hyperprolactinemia (Rai & Regan, 2006; Passos et al., 2023). Other associated conditions include advanced maternal age and lifestyle habits, particularly smoking, excessive alcohol or caffeine intake, illicit drug use, exposure to toxins or radiation, and chronic stress (Ng et al., 2021; Sun et al., 2023). More recently, male factors such as high sperm DNA fragmentation have also been added to the list of RPL risk factors (Tan et al., 2019; Inversetti et al., 2025). Despite the broad range of risk factors and causes, they do not cover all possible etiologies related to the condition. In this context, it is estimated that approximately half of the cases remain unexplained (Saravelos & Regan, 2014; ESHRE Guideline Group on RPL et al., 2023). Due to the high number of idiopathic cases, RPL requires ongoing efforts by the scientific community.
Additionally, a key issue emerges at both the research and clinical levels: the inconsistent use of numerous terms and descriptions. While it remains challenging to determine whether this lack of uniform terminology results from divergent scientific studies or from the absence of standardization among professional societies - or vice versa - the need to clarify this situation has become increasingly clear. This inconsistency impedes the comparison of study results, introduces ambiguity in diagnosis, and makes developing evidence-based clinical protocols more difficult. Therefore, standardizing terminology is crucial - not only to enhance communication among professionals and ensure accurate patient care, but also to strengthen the scientific rigor of research and clinical practice (Rabin et al., 2012; Chae-Kim et al., 2023). A unified term and a consistent definition would enable more accurate data collection, improve identification of etiological patterns, and support more coherent strategies for the prevention, diagnosis, and treatment of RPL. Understanding and harmonizing terms and definitions is not just an academic concern but a vital step toward ensuring research accuracy and implementing more effective and equitable treatments.

DEFINITION AND CLASSIFICATION

Throughout biomedical literature, various terms describe cases of experiencing more than two pregnancy losses, such as “recurrent pregnancy loss,” “recurrent miscarriage,” “recurrent abortion,” “repeated pregnancy loss,” “recurrent spontaneous abortion,” “multiple miscarriages,” “chronic pregnancy loss,” and others. Among these, “recurrent pregnancy loss” is the most comprehensive and neutral term, covering losses at any stage of pregnancy without negative connotations. Conversely, “recurrent miscarriage” usually refers to early pregnancy losses before 20 weeks and does not include later stages. Terms like “recurrent spontaneous abortion” and “recurrent abortion” are more traditional but can carry emotional and social stigma because of the word “abortion,” which may cause discomfort for patients. More descriptive terms such as “multiple miscarriages” or “repeated pregnancy loss” lack formal clinical definitions and may be used inconsistently, while “chronic pregnancy loss” is generally avoided because it incorrectly suggests a persistent condition rather than episodic events.
Due to the lack of standardization, the use of terms becomes arbitrary, as the choice ultimately rests with the individual conveying the information. Not surprisingly, an Irish study on the qualitative perception of RPL among healthcare professionals and patients highlighted the lack of a clear definition of the term in both groups, supporting our concern (Dennehy et al., 2022). This inconsistency impacts the design and interpretation of clinical studies, which are crucial for changing the unfavorable idiopathic statistic. Although the terms essentially refer to the same condition, differences can be identified among studies. A similar trend is seen in the official documents of leading reproductive medical societies (Table 1). When analyzing the guidelines, it is clear that the main discrepancies are primarily in: 1) the number of lost pregnancies considered; 2) whether these are consecutive events or not; and 3) whether the occurrence should be regarded as infertility.

 

Table 1
Table 1. How leading reproductive medicine societies name and define multiple pregnancy loss events.

 

THE NUMBER OF LOST PREGNANCIES

The number of pregnancy losses needed for diagnosis is the first key difference observed (Table 1). There is a consensus in the biomedical literature and among leading societies that a single pregnancy loss should not prompt investigation, as it can be considered an isolated and common event likely caused by known risk factors mentioned earlier. Conversely, there is agreement that waiting until a couple has experienced four or more pregnancy losses before investigation is a waste of time and reflects a lack of medical commitment to patients (Sierra et al., 2025). With this in mind, the main inconsistency lies between considering two or three losses for the definition of RPL. Interestingly, a retrospective study of 383 couples experiencing pregnancy loss showed that the associated risk factors are similar between those with two and three or more losses, with no significant differences (Youssef et al., 2020). These findings were supported by a systematic review and meta-analysis, as well as a comparative study, which concluded that the prevalence of abnormal results in diagnostic tests did not differ significantly between women experiencing two or three losses (Jaslow et al., 2010; Van Dijk et al., 2020). Additionally, a clinical study by Bashiri et al. (2012) demonstrated that, although slight variations in laboratory parameters were observed, these differences did not lead to significant disparities in pregnancy outcomes. Therefore, it appears that two losses already warrant attention from healthcare professionals and should be investigated. A growing consensus supports that clinical investigation after two pregnancy losses is not only justified but desirable, as it anticipates diagnosis, improves early intervention, and reduces the physical, emotional, and financial suffering of affected couples (Sierra et al., 2025). This view is reinforced by partial overlap between RPL evaluation and the diagnostic process for other infertility causes, as well as by the increasing prevalence of delayed childbearing, which heightens the urgency of the diagnostic process.

THE CHRONOLOGY OF EVENTS

Regarding the chronology of events, two points must be considered. The first involves the confusion around the use of the words ‘recurrent’ and ‘consecutive.’ It is important to note that ‘recurrent’ refers to something that happens repeatedly over time but not necessarily continuously, whereas ‘consecutive’ implies immediate succession, with one event following directly after another without interruption. The second point discusses the difference between primary RPL (pRPL) and secondary RPL (sRPL), which relate to the woman’s history of live births. pRPL is defined as all pregnancies ending in loss (spontaneous or stillbirth). Conversely, sRPL is understood as occurring after at least one live birth (Boedeker et al., 2023). This classification helps clarify the causes of RPL. While pRPL appears to be more related to genetic causes, sRPL tends to be associated with acquired causes such as thrombophilia, infections, or postpartum uterine changes (Tersigni et al., 2025).
Relevant clinical and prognostic differences between pRPL and sRPL have already been documented in the literature. In a population-based study, Shapira et al. (2012) observed that women with a prior history of pRPL had a higher incidence of preterm birth, fetal growth restriction, and gestational diabetes compared to those with sRPL. This indicates that different underlying mechanisms may be involved in pRPL and sRPL. Given this evidence, accurate classification and proper use of these terms are crucial for effectively guiding etiological investigations and reproductive counseling. In our view, considering the available labels and the distinction between pRPL and sRPL, it is essential to acknowledge that a healthy pregnancy following losses neither excludes a previous history nor reliably predicts favorable outcomes in future offspring of the couple. This is especially relevant because virtually none of the known etiological factors-genetic, anatomical, immunological, or endocrine-imply a 100% risk of loss, meaning a normal pregnancy cannot serve as a definitive indicator to differentiate between pRPL and sRPL. Furthermore, whether the events are consecutive or not, they still fit within the clinical condition described here. Since the concept of temporality seems to function more theoretically than practically, we recommend using the term ‘recurrent’.

THE RECOGNITION AS INFERTILITY

Infertility is a condition characterized by a couple’s inability to establish a clinical pregnancy after one year (for women up to 35 years old) or six months (for women over 35 years old) of regular attempts to conceive without using contraceptive methods (Zegers-Hochschild et al., 2017a, 2017b). It can be classified as primary, when the couple has never experienced previous pregnancies, and secondary, when the woman has had at least one prior pregnancy, regardless of the outcome, but is unable to conceive again afterward (Zegers-Hochschild et al., 2017a, 2017b; Vander Borght & Wyns, 2018). From this categorization, RPL should be considered a form of infertility, particularly secondary infertility, especially if it has been more than 12 months since the last pregnancy loss. It shares a common characteristic with many other conditions - ultimately preventing a couple from having a live-born child. Notably, couples experiencing RPL often also face difficulties earlier in the process, during attempts to conceive within the period considered “normal.” Furthermore, the investigative approaches for RPL and infertility are similar. Therefore, RPL should not be considered in isolation from the broader concept of infertility. Recognizing RPL within this spectrum is crucial not only for appropriate medical management but also to ensure that couples facing this condition receive the comprehensive care, attention, and support they deserve in their journey toward parenthood.

THE MALE ISSUE

To go further, the discussion can be expanded to whether pregnancy losses occurred within the same couple. Infertility is often still stigmatized, and treatment mainly focuses on women. As already shown here, men are also a vital part of the equation. In this context, it is also unclear whether studies on RPL consistently consider this variable in their design. While there is no doubt that a woman’s previous obstetric events are clinically essential and must be taken into account, should the definition of the concept only consider events between the same couple, or also include previous events of both partners? Can these different situations be combined, or is this sum (losses from previous relationships) insufficient for etiological investigation? This remains an open question, and to the best of our knowledge, it has not been discussed in the literature.

CONCLUSION

All the points mentioned highlight a critical issue that must be addressed: research studies in this field are often flawed, limiting our ability to better understand the condition and treat patients. Due to the lack of standardization in terminology and conceptual understanding, RPL studies are heterogeneous. This heterogeneity occurs both within the same study, where patients are grouped together despite being clinically distinct, and among different studies, due to the lack of criteria in the use of the term. Additionally, systematic reviews and meta-analyses are also hindered for the same reasons. The absence of standardization of a single term or description is just the tip of the iceberg for progress in this area, and the consequences are immeasurable. We may be failing in our decision-making.
To sum up, it is clear that there is an emerging need to standardize the definition and use of the term ‘recurrent pregnancy loss’ to ensure clear communication and consistency in the diagnosis and treatment of the outcome described here. In our opinion, the best way to conceptualize RPL is as “secondary infertility characterized by the occurrence of two or more pregnancy losses.” We strongly advocate for unified and proactive efforts across scientific communities to standardize terminology and improve outcomes for couples who rarely suffer from the disorder.

REFERENCES

American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;78:179-90. PMID: 12360906 DOI: 10.1016/s00207292(02)00197-2 Medline

Bashiri A, Ratzon R, Amar S, Serjienko R, Mazor M, Shoham-Vardi I. Two vs. three or more primary recurrent pregnancy losses--are there any differences in epidemiologic characteristics and index pregnancy outcome? J Perinat Med. 2012;40:365-71. PMID: 22752766 DOI: 10.1515/ jpm-2011-0295 Medline

Boedeker D, Hunkler K, Mahdy H. Recurrent Pregnancy Loss. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2023. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554460/

Chae-Kim J, Patounakis G, Hill MJ. How to deal with confounders in an infertility study? Fertil Steril. 2023;119:897-901. PMID: 36948443 DOI: 10.1016/j. fertnstert.2023.03.014 Medline

Dennehy R, Hennessy M, Meaney S, Matvienko-Sikar K, O’Sullivan-Lago R, Uí Dhubhgain J, Lucey C, O’Donoghue K. How we define recurrent miscarriage matters: A qualitative exploration of the views of people with professional or lived experience. Health Expect. 2022;25:2992-3004. PMID: 36161882 DOI: 10.1111/hex.13607 Medline

ESHRE Guideline Group on RPL; Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, Middeldorp S, Mcheik S, Peramo B, Quenby S, Nielsen HS, van der Hoorn ML, Vermeulen N, Goddijn M. ESHRE guideline: recurrent pregnancy loss: an update in 2022. Hum Reprod Open. 2023;2023:hoad002. PMID: 36873081 DOI: 10.1093/hropen/hoad002 Medline

Goddijn M, van den Boogaard E, Steepers EA, Erwich JJ, Macklon NS, Land JA, Ankum WM. The guideline “Recurrent miscarriage” (first revision) of the Dutch Society for Obstetrics and Gynaecology. Ned Tijdschr Geneeskd. 2008;152:1665-70. PMID: 18714519 Medline

Inversetti A, Bossi A, Cristodoro M, Larcher A, Busnelli A, Grande G, Salonia A, Simone ND. Recurrent pregnancy loss: a male crucial factor-A systematic review and meta-analysis. Andrology. 2025;13:130-45. PMID: 37881014 DOI: 10.1111/andr.13540 Medline

Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril. 2010;93:1234-43. PMID: 19338986 DOI: 10.1016/j.fertnstert.2009.01.166 Medline

Ng KYB, Cherian G, Kermack AJ, Bailey S, Macklon N, Sunkara SK, Cheong Y. Systematic review and meta-analysis of female lifestyle factors and risk of recurrent pregnancy loss. Sci Rep. 2021;11:7081. PMID: 33782474 DOI: 10.1038/s41598-021-86445-2 Medline

Passos EP, Martins-Costa SH, Magalhães JA, Ramos JGL, Oppermann MLR, Wender MCO. Box Rotinas em Ginecologia e Obstetrícia. Porto Alegre: Artmed; 2023.

Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98:1103-11. PMID: 22835448 DOI: 10.1016/j.fertnstert.2012.06.048 Medline

Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2020;113:533-5. PMID: 32115183 DOI: 10.1016/j.fertnstert.2019.11.025 Medline

Rabin BA, Purcell P, Naveed S, Moser RP, Henton MD, Proctor EK, Brownson RC, Glasgow RE. Advancing the application, quality and harmonization of implementation science measures. Implement Sci. 2012;7:119. PMID: 23231885 DOI: 10.1186/1748-5908-7-119 Medline

Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368:601-11. PMID: 16905025 DOI: 10.1016/S01406736(06)69204-0 Medline

Regan L, Rai R, Saravelos S, Li TC; Royal College of Obstetricians and Gynaecologists. Recurrent MiscarriageGreen-top Guideline No. 17. BJOG. 2023;130:e9-e39. PMID: 37334488 DOI: 10.1111/1471-0528.17515 Medline

Saravelos SH, Regan L. Unexplained recurrent pregnancy loss. Obstet Gynecol Clin North Am. 2014;41:15766. PMID: 24491990 DOI: 10.1016/j.ogc.2013.10.008 Medline

Shapira E, Ratzon R, Shoham-Vardi I, Serjienko R, Mazor M, Bashiri A. Primary vs. secondary recurrent pregnancy loss--epidemiological characteristics, etiology, and next pregnancy outcome. J Perinat Med. 2012;40:389-96. PMID: 22752770 DOI: 10.1515/jpm-2011-0315 Medline

Sierra S, Min J, Saumet J, Shapiro H, Sylvestre C, Roberts J, Liu K, Buckett W, Velez MP, Mahutte N. The investigation and management of recurrent early pregnancy loss: a Canadian Fertility and Andrology Society clinical practice guideline. Reprod Biomed Online. 2025;50:104456. PMID: 40015079 DOI: 10.1016/j. rbmo.2024.104456 Medline

Sun H, Lu Y, Qi Q, Li M, Zhou J, Wang J, Lin J, Cao L, Du Y, Li L, Wang L. Advanced age - a critical risk factor for recurrent miscarriage. Glob Health Med. 2023;5:316-8. PMID: 37908515 DOI: 10.35772/ghm.2023.01066 Medline

Tan J, Taskin O, Albert A, Bedaiwy MA. Association between sperm DNA fragmentation and idiopathic recurrent pregnancy loss: a systematic review and meta-analysis. Reprod Biomed Online. 2019;38:951-60. PMID: 30979611 DOI: 10.1016/j.rbmo.2018.12.029 Medline

Tersigni C, Onori M, Beneduce G, Sannino F, Franco R, Busnelli A, Granieri C, Milardi D, Pontecorvi A, Lanzone A, Scambia G, Di Simone N. Primary versus secondary recurrent pregnancy losses: Clinical findings and live birth rate after comprehensive work-up and personalized management. Acta Obstet Gynecol Scand. 2025;104:697-706. PMID: 39835653 DOI: 10.1111/aogs.15050 Medline

van Dijk MM, Kolte AM, Limpens J, Kirk E, Quenby S, Wely M van, Goddijn M. Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis. Hum Reprod Update. 2020;26:356-67. PMID: 32103270 DOI: 10.1093/ humupd/dmz048 Medline

Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018;62:2-10. PMID: 29555319 DOI: 10.1016/j.clinbiochem.2018.03.012 Medline

Youssef A, Lashley L, Dieben S, Verburg H, van der Hoorn ML. Defining recurrent pregnancy loss: associated factors and prognosis in couples with two versus three or more pregnancy losses. Reprod Biomed Online. 2020;41:679-85. PMID: 32811769 DOI: 10.1016/j. rbmo.2020.05.016 Medline

Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, Rienzi L, Sunde A, Schmidt L, Cooke ID, Simpson JL, van der Poel S. The International Glossary on Infertility and Fertility Care, 2017. Hum Reprod. 2017a;32:1786-801. PMID: 29117321 DOI: 10.1093/ humrep/dex234 Medline

Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, Rienzi L, Sunde A, Schmidt L, Cooke ID, Simpson JL, van der Poel S. The International Glossary on Infertility and Fertility Care, 2017. Fertil Steril. 2017b;108:393-406. PMID: 28760517 DOI: 10.1016/j.fertnstert.2017.06.005 Medline